Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
Chao Sun, Xin Zheng, Yingxin Sun, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents
Junya Lv, Lijuan Xing, Xin Zhong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114583-114583
Open Access | Times Cited: 24
Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
Dev Kumar Tripathy, Lakshmi Priya Panda, Suryanarayan Biswal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Effects of RNA methylation on Tumor angiogenesis and cancer progression
Mingyu Han, Haifeng Sun, Quanbo Zhou, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
RNA m6Amethylation in cancer
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
The emerging roles of aberrant alternative splicing in glioma
Reda Ben Mrid, Sara El Guendouzi, Marco Mineo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme
Xi Liu, Jinming Song, Zhiming Zhou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma
Arthur Bassot, Helena Dragic, Sarah Al Haddad, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 12
Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment
Yifu Shu, Jing Li
Frontiers in Immunology (2025) Vol. 16
Open Access
Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases
Siyi You, Xiaojuan Su, Junjie Ying, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 17
m6A mRNA Modifications in Glioblastoma: Emerging Prognostic Biomarkers and Therapeutic Targets
Gloria S. Xie, Hope Richard
Cancers (2024) Vol. 16, Iss. 4, pp. 727-727
Open Access | Times Cited: 3
Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma
Ami Kobayashi, Yosuke Kitagawa, Ali M. Nasser, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 457-457
Open Access | Times Cited: 3
IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization
Jian Qin, Zheng Cui, Jingyi Zhou, et al.
Translational Oncology (2023) Vol. 37, pp. 101764-101764
Open Access | Times Cited: 7
The role and regulatory mechanism of m6A methylation in the nervous system
Lingling Jiang, Xiaoheng Li, Shasha Wang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 10
Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics
Ágota Tűzesi, Susannah Hallal, Laveniya Satgunaseelan, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1232-1232
Open Access | Times Cited: 5
A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain
Yun-Hua Kuo, Huey‐Shan Hung, Chia-Wen Tsai, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3890-3890
Open Access | Times Cited: 8
The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes
Rodrigo Barreiro, Gabriela D. A. Guardia, Fabiana Meliso, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 311-322
Open Access | Times Cited: 4
IGF2BP3-EGFR-AKT axis promotes breast cancer MDA-MB-231 cell growth
Xintao Jing, Cong Han, Qian Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 8, pp. 119542-119542
Closed Access | Times Cited: 4
Interplay of RNA m6A Modification-Related Geneset in Pan-Cancer
B. -B. Zhang, Yajuan Hao, Haiyan Liu, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2211-2211
Open Access | Times Cited: 1
N6-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
Xin Zheng, Shenggang Li, Yu Ju, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 4, pp. 992-1005
Open Access | Times Cited: 3
IMP3 promotes re‐endothelialization after arterial injury via increasing stability of VEGF mRNAhv
Xinmiao Zhou, Qingqing Ye, Jin-Lei Zheng, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 7, pp. 2023-2037
Open Access | Times Cited: 5
Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma
Shenghua Zhuo, Shuo Yang, Shenbo Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Closed Access
The role of Imp and Syp RNA-binding proteins in precise neuronal elimination by apoptosis through the regulation of transcription factors
Wenyue Guan, Ziyan Nie, Anne Laurençon, et al.
eLife (2024) Vol. 12
Open Access
The role of Imp and Syp RBPs in precise neuronal elimination by apoptosis through the regulation of TFs
Wenyue Guan, Ziyan Nie, Anne Laurençon, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 1
m 6 A Modification and its Role in Neural Development and Neurological Diseases
Wan Xin, Yiling Ge, Siyi Xu, et al.
Epigenomics (2023) Vol. 15, Iss. 16, pp. 819-833
Closed Access
The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes
Rodrigo Barreiro, Gabriela D. A. Guardia, Fabiana Meliso, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1 - Next Page

Scroll to top